A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | MicrobiomeTrials← Back to trialsNCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-05-22Est. Completion: 2028-06-12
Enrollment target: 460 participants Locations- Clinnova Research, Anaheim, California, United States
- Peak Gastroenterology Associates, Colorado Springs, Colorado, United States
- GCP Clinical Research, Tampa, Florida, United States
- New York Gastroenterology Associates, New York, New York, United States
- Kagoshima IBD Gastroenterology Clinic, Kagoshima, Japan
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Phase 4
Recruiting
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028